Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
J Oleo Sci ; 69(5): 495-502, 2020.
Article in English | MEDLINE | ID: mdl-32378551

ABSTRACT

We previously reported that soy ß-conglycinin (ßCG) improves obesity-induced metabolic abnormalities, but not obesity, in obese model Otsuka Long-Evans Tokushima fatty (OLETF) rats. In the present study, we aimed to investigate the effects of ßCG-derived peptide consumption on obesity and lipid abnormality in OLETF rats. To this end, wild-type Long-Evans Tokushima Otsuka and OLETF rats were provided a normal diet containing 20% casein for four weeks as a control. In addition, we prepared ßCG peptide by enzymatic hydrolysis, and OLETF rats were fed a diet in which half of the casein was replaced by ßCG peptide (ßCG peptide group). Consequently, rats in the ßCG peptide group showed decreased abdominal white adipose tissue weight and lipid content (serum and liver triglycerides, and serum and liver cholesterol) compared to control OLETF rats. Further analysis demonstrated that ßCG peptide consumption decreased lipogenic enzyme activity and increased lipolytic enzyme activity in the liver of OLETF rats. In addition, suppressive effects on both synthesis and absorption of cholesterol were observed in ßCG peptide-fed OLETF rats. These findings suggest that peptidization of ßCG enhanced the anti-obese and hypolipidemic effects of ßCG.


Subject(s)
Antigens, Plant/pharmacology , Antigens, Plant/therapeutic use , Globulins/pharmacology , Globulins/therapeutic use , Glycine max/chemistry , Lipid Metabolism/drug effects , Obesity/drug therapy , Obesity/metabolism , Phytotherapy , Seed Storage Proteins/pharmacology , Seed Storage Proteins/therapeutic use , Soybean Proteins/pharmacology , Soybean Proteins/therapeutic use , Animals , Antigens, Plant/isolation & purification , Disease Models, Animal , Globulins/isolation & purification , Male , Rats, Inbred OLETF , Seed Storage Proteins/isolation & purification , Soybean Proteins/isolation & purification
2.
J Oleo Sci ; 68(4): 339-350, 2019 Apr 01.
Article in English | MEDLINE | ID: mdl-30867392

ABSTRACT

The physiological effects of dietary ß-conglycinin (ß-CON), one of the major components of soy protein (SOY), were examined in an obese animal model. Prior studies show that ß-CON intake decreases plasma triglycerides and visceral adipose tissue weight, and increases plasma adiponectin in rodents. Since plasma adiponectin is known to affect both lipid and glucose metabolism, feeding a diet containing ß-CON could modulate insulin sensitivity. Therefore, we examined the effects of dietary ß-CON on insulin sensitivity and blood glucose levels, as well as lipid metabolism in obese Otsuka Long-Evans Tokushima Fatty (OLETF) rats (pre-symptomatic stage of type 2 diabetes mellitus). Male OLETF rats (6 weeks old) were fed diets containing 20% protein such as casein (CAS), CAS replaced with soy protein (SOY), or ß-CON at a proportion of 50% for 13 weeks. Fasting blood glucose levels were measured every 3 weeks, and an insulin tolerance test (ITT; 0.75 IU/kg body weight) was conducted at week 12. During the feeding period, fasting blood glucose was comparable among the groups. Insulin sensitivity measured by the ITT revealed that the SOY and ß-CON diets decreased blood glucose levels at 30 min after intraperitoneal insulin injection (vs. CAS diet). In addition, the ß-CON diet increased plasma adiponectin concentrations, hepatic gene expression of insulin receptor substrate (IRS) 2, and muscle gene expression of adiponectin receptor 1 (AdipoR1) and IRS1, and with a decrease in plasma insulin concentration. Finally, the ß-CON diet decreased the mesenteric adipose tissue weight and liver triglyceride concentration compared to the CAS diet. These results suggest that the metabolic effects of dietary ß-CON are mediated by increasing plasma adiponectin to increase insulin sensitivity and influence the hepatic lipid metabolism in obese OLETF rats.


Subject(s)
Adipose Tissue/metabolism , Antigens, Plant/administration & dosage , Antigens, Plant/pharmacology , Dietary Supplements , Globulins/administration & dosage , Globulins/pharmacology , Insulin Resistance/physiology , Lipid Metabolism/drug effects , Obesity/metabolism , Seed Storage Proteins/administration & dosage , Seed Storage Proteins/pharmacology , Soybean Proteins/administration & dosage , Soybean Proteins/pharmacology , Adiponectin/blood , Animals , Blood Glucose/metabolism , Disease Models, Animal , Insulin Receptor Substrate Proteins/metabolism , Liver/metabolism , Male , Rats, Inbred OLETF , Receptors, Adiponectin/metabolism , Triglycerides/blood , Triglycerides/metabolism
3.
Gynecol Endocrinol ; 35(4): 360-363, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30741042

ABSTRACT

Safety concerns or contraindications to the use of hormones have resulted in a rise of the use of herbal medicinal products for the management of menopausal symptoms. The pollen extract Sérélys® represents, due to its ingredients and mode of action, a new and innovative alternative for the management of these symptoms. The aim of the present study was to demonstrate the efficacy and safety of Sérélys®. A prospective, open, observational, and multicentre study was performed on 104 menopausal women. The patients received over 3 months the pollen extract Sérélys® containing the extracts PI82 and GC Fem in a dosage of twice 160 mg extract and 5 mg vitamin E. Using a validated menopausal rating score, the improvement of menopausal symptoms was recorded. A significant decrease of different menopausal symptoms was observed between the starting point of the study and after 12 weeks (p < .0001). Hot flashes were reduced by 48.5%, sleep disturbance by 50.1%, depressive mood by 51.2%, irritability by 47.9%, fatigue by 47.8%, vaginal dryness by 39.63% and muscles and joint pain by 27.4%. The pollen extract Sérélys® reduced significant menopausal symptoms showing a very low side effect profile.


Subject(s)
Antigens, Plant/therapeutic use , Hot Flashes/drug therapy , Menopause/drug effects , Phytotherapy , Plant Extracts/therapeutic use , Pollen , Vitamin E/therapeutic use , Antigens, Plant/pharmacology , Depression/drug therapy , Female , Humans , Middle Aged , Plant Extracts/pharmacology , Prospective Studies , Sleep Wake Disorders/drug therapy , Vasomotor System/drug effects , Vitamin E/pharmacology
4.
Food Chem ; 272: 201-209, 2019 Jan 30.
Article in English | MEDLINE | ID: mdl-30309533

ABSTRACT

The effects of selenium (Se) on the protein content, amino acid profile, secondary structure and subunit composition of soy proteins and its distribution were evaluated, as was the effect of peroxyl radicals produced by thermal decomposition of AAPH on the conformational changes of Se-enriched ß-conglycinin (S-7S). The Se biofortification ability of soy was very strong, 7S had strongest ability to incorporate Se, and lower amounts of inorganic Se existed in Se-enriched beans. Se could promote protein synthesis and thus improve the protein content, increase the total amino acid content with a decrease in cysteine, combine into low-molecular-weight proteins, and influence the secondary structure of soybean proteins. Se was involved in the relevant protein changes in surface hydrophobicity, intrinsic fluorescence, infrared absorption and solubility and played an antioxidant role as an effectual "protector" to reduce the influence of peroxyl radical oxidation on S-7S, thereby maintaining the structural rearrangement between aggregation and protein unfolding.


Subject(s)
Amidines/pharmacology , Antigens, Plant/chemistry , Antigens, Plant/pharmacology , Globulins/chemistry , Globulins/pharmacology , Oxidative Stress/drug effects , Seed Storage Proteins/chemistry , Seed Storage Proteins/pharmacology , Selenium/analysis , Soybean Proteins/chemistry , Soybean Proteins/pharmacology , Molecular Weight , Protein Structure, Secondary
5.
Eur J Pharmacol ; 805: 125-130, 2017 Jun 15.
Article in English | MEDLINE | ID: mdl-28219711

ABSTRACT

Examined in the present study, allopurinol are xanthine oxidase inhibitors for use in rat hearts in vivo dialysis technology and ventricular myocardial intersitial adenosine production can increase. The microdialysis probe was implanted in the left ventricular myocardium of anesthetized rat hearts and the tissue in the vicinity of the dialysis was perfused with Tyrode's solution containing adenosine 5'-monophosphate (AMP) through the dialysis probe at a rate of 1.0ml/min to assess the activity of ecto-5'-nucleotidase. Allopurinol (10µM) significantly increased the level of adenosine in rat heart dialysate (n=6, p<0.05), which was inhibited by chelerythrine, 10µM, an antagonist of protein kinase C (PKC). Another free radical scavenger, coenzyme Q10 (CoQ10, 100µM) or ascorbic acid (Vitamin C; 100µM) also increased adenosine production. In addition, allopurinol enhanced the diacylglycerol (DAG; 50µM)-induced also increases in adenosine production by 71.5±12.0% (n=6, P<0.05), to a level significantly (P<0.05) greater than the increase caused by DAG alone (33.0±10.6%). In the presence of allopurinol (10µM), a marked elevation of AMP-primed dialysate adenosine in ischemia/reperfused rat hearts was observed. Free radical generation may suppress adenosine production via activation of PKC. The results suggest that oxidative stress may cause inactivation of nucleotidase, adenosine production in rat heart.


Subject(s)
5'-Nucleotidase/metabolism , Myocardium/metabolism , Oxidative Stress , Protein Kinase C/antagonists & inhibitors , Protein Kinase Inhibitors/pharmacology , Adenosine/pharmacology , Animals , Antigens, Plant/pharmacology , Enzyme Activation/drug effects , Male , Myocardial Reperfusion Injury/metabolism , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Rats , Rats, Wistar
7.
Immunol Res ; 65(3): 658-665, 2017 06.
Article in English | MEDLINE | ID: mdl-28124732

ABSTRACT

Ganoderma lucidum (Fr.) Karst (Ganodermataceae) is a medicinal mushroom that has been extensively used in China for centuries to promote longevity and improve vigor without significant adverse effects. There is continuous interest in the bioactive properties of G. lucidum in view of its newly developed popularity in other regions besides Asia, such as Europe. Glycopeptide derived from G. lucidum (Gl-PS) is one of the main effective components isolated from this mushroom. The Gl-PS has been demonstrated pleiotropic with many bioactivities including immunomodulatory and antitumor effects. Macrophages are important cells involved in innate and adaptive immunity. Classically activated macrophages (M1) and alternatively activated macrophages (M2), with their different roles, display distinct cytokine profiles: M1 preferentially produces TNF-α, IL-6, and IL-12; conversely, M2 generates more IL-10 and arginase. Gl-PS might have the potential to promote macrophage M1 polarization by lipopolysaccharide (LPS). In this study, LPS was used to induce the M1 polarization. It was shown that the level of the TNF-α, IL-6, and IL-12 were increased and the IL-10 and arginase I were decreased in the polarized M1 macrophages after application of Gl-PS compared to the control. The results indicated the potential of Gl-PS to promote M1 polarization vs M2, with the health beneficial understanding of the bioactivities of Gl-PS.


Subject(s)
Antigens, Plant/pharmacology , Glycopeptides/pharmacology , Macrophages, Peritoneal/immunology , Animals , Arginase/metabolism , Cell Differentiation/drug effects , Cells, Cultured , Cytokines/metabolism , Inflammation Mediators/metabolism , Macrophage Activation/drug effects , Macrophages, Peritoneal/parasitology , Medicine, Chinese Traditional , Mice , Mice, Inbred C57BL , Reishi/immunology
8.
Mol Nutr Food Res ; 61(4)2017 04.
Article in English | MEDLINE | ID: mdl-28070926

ABSTRACT

SCOPE: English walnut (Juglans regia) belongs to the most important allergenic tree nuts. Co-sensitization with birch (Betula verrucosa) pollen has been reported. We aimed to identify a walnut allergen homologous to the major birch pollen allergen Bet v 1. METHODS AND RESULTS: A cDNA encoding a Bet v 1-homologous allergen (Jug r 5) in walnut kernels was cloned by RT-PCR. Jug r 5 was expressed in Escherichia coli, purified by column chromatography and characterized by circular dichroism spectroscopy. Specific IgE levels to walnut, Bet v 1, and Jug r 5 in birch pollen allergics (n = 16) with concomitant walnut allergy were measured by ImmunoCAP: 44% of the patients were tested positive to walnut while 94% were reactive to Jug r 5, and 100% to Bet v 1. Jug r 5 and Bet v 1 allergens showed bidirectional IgE cross-reactivity by competitive ELISA and were capable of inducing histamine release from effector cells. Immunoblot competition experiments demonstrated the presence of IgE-reactive Jug r 5 in walnut extract, but at low levels. CONCLUSION: A Bet v 1-like allergen was identified in walnut. Diagnostic use of Jug r 5 will compensate for the low sensitivity of walnut extract for patients with birch pollen associated walnut allergy.


Subject(s)
Allergens/immunology , Antigens, Plant/pharmacology , Betula/chemistry , Hypersensitivity , Juglans/chemistry , Plant Proteins/metabolism , Pollen/immunology , Amino Acid Sequence , Antigens, Plant/metabolism , Cross Reactions , Female , Histamine Release , Humans , Immunoblotting , Immunoglobulin E/immunology , Nuts/immunology , Plant Proteins/immunology
9.
Nutrients ; 8(8)2016 Aug 11.
Article in English | MEDLINE | ID: mdl-27529274

ABSTRACT

Soybean is recognized as a beneficial food with various functional components, such as ß-conglycinin, which improves lipid metabolism. We evaluated the effects of the ß-conglycinin-rich soybean Nanahomare on triglyceride (TG) levels. In this randomized, double-blind, placebo-controlled study, we divided 134 adult subjects into test and placebo groups that consumed processed food containing enriched-ß-conglycinin soybean or low-ß-conglycinin soybean. Hematological tests and body composition measurements were performed at weeks 0 (baseline), 4, 8, and 12 of the study period. TG levels significantly decreased in the test group compared with the placebo group at weeks 4 (change from baseline to week 4, placebo: 0.27 ± 44.13 mg/dL, test: -20.31 ± 43.74 mg/dL, p = 0.035) and 12 (change from baseline to week 12, placebo: -0.14 ± 65.83 mg/dL, test: -21.30 ± 46.21 mg/dL, p = 0.041). In addition, among subjects whose baseline TG levels were ≥100 mg/dL, the levels significantly improved in the test group at weeks 4 (p = 0.010) and 12 (p = 0.030), whereas the levels were not different between the test and placebo groups among those whose baseline levels were <100 mg/dL. These results suggest that the ingestion of enriched-ß-conglycinin soybean improves serum TG levels.


Subject(s)
Antigens, Plant/pharmacology , Eating/physiology , Food, Fortified , Globulins/pharmacology , Glycine max/chemistry , Seed Storage Proteins/pharmacology , Soybean Proteins/pharmacology , Triglycerides/blood , Adult , Aged , Body Composition/drug effects , Double-Blind Method , Female , Humans , Male , Middle Aged , Time Factors
10.
J Immunol ; 195(2): 445-9, 2015 Jul 15.
Article in English | MEDLINE | ID: mdl-26041541

ABSTRACT

Olive (Olea europaea) pollen constitutes one of the most important allergen sources in the Mediterranean countries and some areas of the United States, South Africa, and Australia. Recently, we provided evidence that olive pollen releases nanovesicles of respirable size, named generically pollensomes, during in vitro germination. Olive pollensomes contain allergens, such as Ole e 1, Ole e 11, and Ole e 12, suggesting a possible role in allergy. The aim of this study was to assess the contribution of pollensomes to the allergic reaction. We show that pollensomes exhibit allergenic activity in terms of patients' IgE-binding capacity, human basophil activation, and positive skin reaction in sensitized patients. Furthermore, allergen-containing pollensomes have been isolated from three clinically relevant nonphylogenetically related species: birch (Betula verrucosa), pine (Pinus sylvestris), and ryegrass (Lolium perenne). Most interesting, pollensomes were isolated from aerobiological samples collected with an eight-stage cascade impactor collector, indicating that pollensomes secretion is a naturally occurring phenomenon. Our findings indicate that pollensomes may represent widespread vehicles for pollen allergens, with potential implications in the allergic reaction.


Subject(s)
Basophils/immunology , Hypersensitivity/immunology , Pollen/immunology , Animals , Antigens, Plant/isolation & purification , Antigens, Plant/pharmacology , Basophil Degranulation Test , Basophils/drug effects , Basophils/pathology , Betula/chemistry , Betula/immunology , Case-Control Studies , Germination , Humans , Hypersensitivity/blood , Hypersensitivity/pathology , Immune Sera/chemistry , Immunoglobulin E/blood , Lolium/chemistry , Lolium/immunology , Mice , Olea/chemistry , Olea/immunology , Pinus/chemistry , Pinus/immunology , Plant Extracts/chemistry , Plant Extracts/immunology , Plant Proteins/isolation & purification , Plant Proteins/pharmacology , Pollen/chemistry , Primary Cell Culture
11.
Int Immunopharmacol ; 27(1): 104-9, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25962819

ABSTRACT

The effects of two selenizing polysaccharides (sCAP2 and sGPS6) on immune function of murine peritoneal macrophages taking two non-selenizing polysaccharides (CAP and GPS) and modifier Na2SeO3 as control. In vitro test, the changes of selenizing polysaccharides, non-selenizing polysaccharides and Na2SeO3 on murine macrophages function were evaluated by phagocytosis and nitric oxide (NO) secretion tests. In vivo test, the mice were injected respectively with 0.2, 0.4 and 0.6 mg of sCAP2, sGPS6, CAP and GPS, or Na2SeO3 80 µg or normal saline 0.4 mL. The peritoneal macrophages were collected and cultured to determine the contents of TNF-α, IL-6 and IL-10 in supernatants by enzyme-linked immunosorbent assay. The results showed that sCAP2 and sGPS6 could significantly promote the phagocytosis and secretion of NO and three cytokines of macrophages in comparison with CAP and GPS. sCAP2 possessed the strongest activity. This indicates that selenylation modification can further improve the immune-enhancing activity of polysaccharide, and sCAP2 could be as a new immunopotentiator.


Subject(s)
Antigens, Plant/pharmacology , Macrophages, Peritoneal/drug effects , Polysaccharides/pharmacology , Selenium Oxides/pharmacology , Angelica/immunology , Animals , Antigens, Plant/chemistry , Cells, Cultured , Cytokines/metabolism , Female , Garlic/immunology , Immunity, Cellular/drug effects , Immunization , Inflammation Mediators/metabolism , Macrophages, Peritoneal/immunology , Mice , Mice, Inbred ICR , Nitric Oxide/metabolism , Phagocytosis/drug effects , Polysaccharides/chemistry
12.
Obes Res Clin Pract ; 9(2): 168-74, 2015.
Article in English | MEDLINE | ID: mdl-25890430

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) has a variety of causes including calorie over-intake, an unbalanced diet, and/or genetic dysfunction of lipid metabolism. We hypothesized that NAFLD symptoms could be mitigated by specific nutritional factors. Here, we show that the potential for soy ß-conglycinin (ßCG) to improve obesity-induced metabolic abnormalities in the Otsuka Long Evans Tokushima fatty (OLETF) rat model of NAFLD. Long Evans Tokushima Otsuka (i.e., wild-type) and OLETF rats were provided a normal diet containing 20% casein for 4 weeks as a control. In a third (ßCG) group, OLETF rats were fed a diet in which half of the casein was replaced by ßCG. There was no difference in food intake between groups. Rats in the ßCG group had decreased liver weight and lipid content (triglycerides, cholesterol, and phospholipids) compared to controls. In addition, ßCG consumption decreased fatty acid synthase gene expression and enzymatic activity. These findings indicate that dietary intake of ßCG can improve obesity-induced metabolic dysfunction, possibly via suppression of de novo fatty acid synthesis.


Subject(s)
Antigens, Plant/therapeutic use , Dietary Proteins/therapeutic use , Globulins/therapeutic use , Glycine max/chemistry , Lipogenesis/drug effects , Liver/drug effects , Non-alcoholic Fatty Liver Disease/diet therapy , Obesity/metabolism , Seed Storage Proteins/therapeutic use , Soybean Proteins/therapeutic use , Animals , Antigens, Plant/pharmacology , Dietary Proteins/pharmacology , Gene Expression/drug effects , Globulins/pharmacology , Lipids/blood , Lipogenesis/genetics , Liver/metabolism , Male , Non-alcoholic Fatty Liver Disease/metabolism , Obesity/complications , Organ Size/drug effects , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Rats , Rats, Inbred OLETF , Seed Storage Proteins/pharmacology , Soybean Proteins/pharmacology
13.
Mol Immunol ; 64(2): 252-61, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25553522

ABSTRACT

Two regions of Ole e 1, the major olive-pollen allergen, have been characterized as T-cell epitopes, one as immunodominant region (aa91-130) and the other, as mainly recognized by non-allergic subjects (aa10-31). This report tries to characterize the specific relevance of these epitopes in the allergic response to olive pollen by analyzing the secreted cytokines and the gene expression profiles induced after specific stimulation of peripheral blood mononuclear cells (PBMCs). PBMCs from olive pollen-allergic and non-allergic control subjects were stimulated with olive-pollen extract and Ole e 1 dodecapeptides containing relevant T-cell epitopes. Levels of cytokines were measured in cellular supernatants and gene expression was determined by microarrays, on the RNAs extracted from PBMCs. One hundred eighty-nine differential genes (fold change >2 or <-2, P<0.05) were validated by qRT-PCR in a large population. It was not possible to define a pattern of response according the overall cytokine results but interesting differences were observed, mainly in the regulatory cytokines. Principal component (PCA) gene-expression analysis defined clusters that correlated with the experimental conditions in the group of allergic subjects. Gene expression and functional analyses revealed differential genes and pathways among the experimental conditions. A set of 51 genes (many essential to T-cell tolerance and homeostasis) correlated with the response to aa10-31 of Ole e 1. In conclusion, two peptides derived from Ole e 1 could regulate the immune response in allergic patients, by gene-expression modification of several regulation-related genes. These results open new research ways to the regulation of allergy by Oleaceae family members.


Subject(s)
Antigens, Plant/immunology , Epitopes, T-Lymphocyte/immunology , Leukocytes, Mononuclear/immunology , Oligopeptides/immunology , Plant Proteins/immunology , Pollen/immunology , Rhinitis, Allergic, Seasonal/immunology , Adult , Amino Acid Sequence , Antigens, Plant/pharmacology , Case-Control Studies , Epitopes, T-Lymphocyte/chemistry , Epitopes, T-Lymphocyte/genetics , Female , Gene Expression Profiling , Gene Expression Regulation , Genetic Markers , Humans , Immunoglobulin E/blood , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/pathology , Male , Middle Aged , Molecular Sequence Data , Multigene Family , Olea/chemistry , Olea/immunology , Oligopeptides/chemical synthesis , Oligopeptides/pharmacology , Plant Proteins/pharmacology , Pollen/chemistry , Primary Cell Culture , Principal Component Analysis , Rhinitis, Allergic, Seasonal/blood , Rhinitis, Allergic, Seasonal/physiopathology
14.
Int J Mol Sci ; 16(1): 2117-29, 2015 Jan 19.
Article in English | MEDLINE | ID: mdl-25607735

ABSTRACT

Phytate-removed and deamidated soybean ß-conglycinin (PrDS) prepared by ion-exchange resins was supplemented to be 4% in the diet administered to ovariectomized rats to investigate its preventive effect on osteoporosis. The apparent calcium absorption rate decreased following ovariectomy and was not replenished by oral administration of phytate-removed soybean ß-conglycinin (PrS) or casein. On the other hand, administration of PrDS restored the calcium absorption rate to the same level as the sham group. Markers of bone resorption, such as serum parathyroid hormone (PTH) and urinary deoxypyridinoline (DPD), increased, and the bone mineral density and breaking stress decreased following ovariectomy. However, PrDS supplementation suppressed the changes caused by the decrease in calcium absorption from the small intestine. Therefore, PrDS supplementation shows promise for the prevention of postmenopausal osteoporosis.


Subject(s)
Amides/isolation & purification , Antigens, Plant/administration & dosage , Antigens, Plant/therapeutic use , Globulins/administration & dosage , Globulins/therapeutic use , Osteoporosis/drug therapy , Osteoporosis/prevention & control , Phytic Acid/isolation & purification , Seed Storage Proteins/administration & dosage , Seed Storage Proteins/therapeutic use , Soybean Proteins/administration & dosage , Soybean Proteins/therapeutic use , Absorption, Physiological/drug effects , Administration, Oral , Amino Acids/urine , Animals , Antigens, Plant/pharmacology , Biomechanical Phenomena/drug effects , Bone Density/drug effects , Bone and Bones/drug effects , Bone and Bones/physiopathology , Female , Globulins/pharmacology , Minerals/metabolism , Osteoporosis/blood , Osteoporosis/urine , Ovariectomy , Parathyroid Hormone/blood , Rats, Wistar , Seed Storage Proteins/pharmacology , Soybean Proteins/pharmacology
15.
Nutr Res ; 34(2): 160-7, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24461318

ABSTRACT

Although the underlying mechanism is unclear, ß-conglycinin (ßCG), the major component of soy proteins, regulates blood glucose levels. Here, we hypothesized that consumption of ßCG would normalize blood glucose levels by ameliorating insulin resistance and stimulating glucose uptake in skeletal muscles. To test our hypothesis, we investigated the antidiabetic action of ßCG in spontaneously diabetic Goto-Kakizaki (GK) rats. Our results revealed that plasma adiponectin levels and adiponectin receptor 1 messenger RNA expression in skeletal muscle were higher in ßCG-fed rats than in casein-fed rats. Phosphorylation of adenosine monophosphate-activated protein kinase (AMP kinase) but not phosphatidylinositol-3 kinase was activated in ßCG-fed GK rats. Subsequently, ßCG increased translocation of glucose transporter 4 to the plasma membrane. Unlike the results in skeletal muscle, the increase in adiponectin receptor 1 did not lead to AMP kinase activation in the liver of ßCG-fed rats. The down-regulation of sterol regulatory element-binding factor 1, which is induced by low insulin levels, promoted the increase in hepatic insulin receptor substrate 2 expression. Based on these findings, we concluded that consumption of soy ßCG improves glucose uptake in skeletal muscle via AMP kinase activation and ameliorates hepatic insulin resistance and that these actions may help normalize blood glucose levels in GK rats.


Subject(s)
Antigens, Plant/pharmacology , Globulins/pharmacology , Glucose/metabolism , Glycine max/chemistry , Insulin Resistance , Insulin/metabolism , Liver/drug effects , Muscle, Skeletal/drug effects , Seed Storage Proteins/pharmacology , Soybean Proteins/pharmacology , AMP-Activated Protein Kinases/metabolism , Adiponectin/blood , Animals , Antigens, Plant/therapeutic use , Biological Transport , Diabetes Mellitus/drug therapy , Globulins/therapeutic use , Glucose Transporter Type 4/metabolism , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/therapeutic use , Insulin Receptor Substrate Proteins/metabolism , Liver/metabolism , Male , Muscle, Skeletal/metabolism , Phosphorylation , Phytotherapy , Rats , Rats, Inbred Strains , Receptors, Adiponectin/genetics , Receptors, Adiponectin/metabolism , Seed Storage Proteins/therapeutic use , Soybean Proteins/therapeutic use , Sterol Regulatory Element Binding Protein 1/metabolism
16.
Br J Nutr ; 111(1): 78-85, 2014 Jan 14.
Article in English | MEDLINE | ID: mdl-23803175

ABSTRACT

The objective of the present study was to investigate the effects of ß-conglycinin and soya isoflavones on diabetic nephropathy (DN). DN was induced by an intravenous injection of streptozotocin (25 mg/kg) in spontaneously hypertensive rats. DN rats were divided into a non-diabetic group (C, control group) and three DN groups (D, DN with control diet; B, DN+control diet with one-eighth of casein replaced by ß-conglycinin as the protein source; and I, DN+control diet with 0·01 % soya isoflavones). After a 4-week experimental period, we found that fasting blood sugar and plasma and kidney advanced glycation end product levels and 24 h urinary protein excretion of the B group were significantly lower than those of the D group and insulin sensitivity and nephrin expression of the B group were significantly higher than those of the D group. In addition, systolic blood pressure, angiotensin-converting enzyme activity, angiotensin II level and plasma TAG level of the B group were significantly lower than those of the D group, whereas only the levels of plasma TAG and thiobarbituric acid-reactive substances of the I group were lower than those of the D group. In conclusion, ß-conglycinin may be beneficial for retarding DN progression and this effect cannot be completely explained by its isoflavone content.


Subject(s)
Antigens, Plant/therapeutic use , Diabetic Nephropathies/diet therapy , Dietary Proteins/therapeutic use , Globulins/therapeutic use , Glycine max/chemistry , Isoflavones/pharmacology , Kidney/drug effects , Membrane Proteins/metabolism , Seed Storage Proteins/therapeutic use , Soybean Proteins/therapeutic use , Angiotensin II/blood , Animals , Antigens, Plant/pharmacology , Blood Glucose/metabolism , Blood Pressure/drug effects , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/diet therapy , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/physiopathology , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/diet therapy , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/physiopathology , Diabetic Nephropathies/metabolism , Diabetic Nephropathies/physiopathology , Dietary Proteins/pharmacology , Globulins/pharmacology , Glycation End Products, Advanced/metabolism , Insulin Resistance , Kidney/metabolism , Kidney/physiopathology , Male , Peptidyl-Dipeptidase A/metabolism , Phytotherapy , Plant Preparations/pharmacology , Plant Preparations/therapeutic use , Rats , Rats, Inbred SHR , Seed Storage Proteins/pharmacology , Soybean Proteins/pharmacology , Thiobarbituric Acid Reactive Substances , Triglycerides/blood
17.
Int J Food Sci Nutr ; 65(3): 345-50, 2014 May.
Article in English | MEDLINE | ID: mdl-24224901

ABSTRACT

Peptides derived from alcalase digestion of soybean ß-conglycinin, containing 8.52% carbohydrate, exhibits an inhibition effect on pathogen adhesion or translocation to intestinal cells in vitro. In this study, the protective and reparative effects of ß-conglycinin peptides on intestinal mucosa injury in vivo were studied using mice with dextran sulfate sodium (DSS)-induced intestinal mucosa injury. The results showed that ß-conglycinin peptides contained approximately 21.77% glutamic acid (Glu), and significantly reduced the histological injury in mice both in the protective and reparative experiments. The myeloperoxidase activity of mice treated with ß-conglycinin peptides decreased compared with those treated DSS in the positive control group. Immunohistochemical analysis also showed that ß-conglycinin peptides inhibited the expression of inflammatory factor NF-κB/p65. These results suggested that peptides derived from soybean ß-conglycinin exhibited protective and reparative effects on mice intestinal mucosa injury.


Subject(s)
Antigens, Plant/therapeutic use , Colitis/drug therapy , Globulins/therapeutic use , Glycine max/chemistry , Intestinal Mucosa/drug effects , Peptides/therapeutic use , Seed Storage Proteins/therapeutic use , Soybean Proteins/therapeutic use , Animals , Antigens, Plant/pharmacology , Colitis/chemically induced , Colitis/metabolism , Colitis/pathology , Colon/drug effects , Colon/metabolism , Colon/pathology , Dextran Sulfate , Female , Globulins/pharmacology , Inflammation Mediators/metabolism , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Mice , Mice, Inbred BALB C , NF-kappa B/metabolism , Peptides/pharmacology , Seed Storage Proteins/pharmacology , Soybean Proteins/pharmacology
18.
Br J Nutr ; 110(9): 1680-4, 2013 Nov 14.
Article in English | MEDLINE | ID: mdl-23561330

ABSTRACT

To evaluate the effect of treatment with ß-conglycinin, a major soyabean protein, on blood lipids in menopausal women, we recruited 100 hyperlipidaemic women aged 40-60 years old. Participants were randomly allocated to three groups: placebo group (n 34, four casein tablets/d); low dose group (n 33, four tablets containing 2·3 g ß-conglycinin/d); high-dose group (n 33, eight tablets containing 4·6 g ß-conglycinin/d). The mean serum TAG concentration was significantly reduced after 6 and 12 weeks of ß-conglycinin intervention by 0·44 (sd 0·20) and 0·78 (sd 1·03) mmol/l in the low-dose group, and by 0·46 (sd 0·17) and 1·25 (sd 1·06) mmol/l in the high-dose group, respectively. One-way ANOVA revealed that serum TAG concentrations in the low-dose and high-dose groups were significantly lowered compared with the placebo group at weeks 6 and 12 (P< 0·05). The low dose and high dose consumptions of ß-conglycinin significantly decreased the LDL-cholesterol concentration by 0·46 (sd 0·72) and 0·52 (sd 0·97) mmol/l at week 12, respectively (P< 0·05). Compared with the changes from baseline in the placebo group, apoB and NEFA were significantly lowered in both the low-dose and high-dose ß-conglycinin groups (P< 0·05). In conclusion, the results suggest that ß-conglycinin intake significantly decreases serum TAG and LDL-cholesterol levels.


Subject(s)
Antigens, Plant/therapeutic use , Cholesterol, LDL/blood , Globulins/therapeutic use , Glycine max/chemistry , Hyperlipidemias/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Seed Storage Proteins/therapeutic use , Soybean Proteins/therapeutic use , Triglycerides/blood , Analysis of Variance , Antigens, Plant/pharmacology , Apolipoproteins B/blood , Fatty Acids, Nonesterified/blood , Female , Globulins/pharmacology , Humans , Hyperlipidemias/blood , Menopause , Middle Aged , Plant Extracts/pharmacology , Seed Storage Proteins/pharmacology , Soybean Proteins/pharmacology
19.
Immunology ; 138(4): 392-401, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23278511

ABSTRACT

Ragweed pollen extract (RWE) possesses intrinsic NADPH oxidase activity that induces oxidative stress by initiating the production of intracellular reactive oxygen species (ROS). The ROS are important contributors to the manifestation of allergic inflammation; furthermore, concomitant exposure to an allergen and an endotoxin trigger a stronger inflammatory response. One of the main pro-inflammatory cytokines produced in inflammatory responses is interleukin-1ß (IL-1ß), and its production is associated with caspase-1-containing inflammasome complexes. Intracellular ROS have been implicated in NLRP3 inflammasome-mediated IL-1ß production, therefore, we aimed to study whether RWE influences the function of NLRP3 inflammasome. Here we describe that, in the presence of NADPH, RWE significantly elevates lipopolysaccharide-induced IL-1ß production of THP-1 cells as well as human primary macrophages and dendritic cells. We also demonstrate that increased IL-1ß production is mediated through NLRP3 inflammasome in THP-1 macrophages. We provide evidence that RWE elevates cytosolic ROS level in these cells, and ROS inhibitors abolish IL-1ß production. Furthermore, we show that RWE enhances lipopolysaccharide-induced gene transcription/expression of pro-IL-1ß and key components of the inflammasome via a ROS-dependent mechanism.


Subject(s)
Antigens, Plant/therapeutic use , Carrier Proteins/immunology , Inflammasomes/drug effects , Interleukin-1beta/immunology , Macrophages/drug effects , Plant Extracts/pharmacology , Antigens, Plant/immunology , Antigens, Plant/pharmacology , Carrier Proteins/genetics , Caspase 1/genetics , Caspase 1/immunology , Cell Line , Free Radical Scavengers/pharmacology , Humans , Inflammasomes/genetics , Inflammasomes/immunology , Inflammation/immunology , Inflammation/pathology , Interleukin-1beta/genetics , Lipopolysaccharides/pharmacology , Macrophage Activation/drug effects , Macrophages/cytology , Macrophages/immunology , NADP/metabolism , NADP/pharmacology , NLR Family, Pyrin Domain-Containing 3 Protein , Plant Extracts/immunology , Reactive Oxygen Species/antagonists & inhibitors , Transcription, Genetic/drug effects
20.
Biosci Biotechnol Biochem ; 76(6): 1104-9, 2012.
Article in English | MEDLINE | ID: mdl-22790930

ABSTRACT

We have recently reported that oral gavage of a potato extract (Potein®) suppressed the food intake in rats. The satiating effect of the potato extract was compared in the present study to other protein sources, and the involvement of endogenous cholecystokinin (CCK) secretion was examined. Food consumption was measured in 18-h fasted rats after oral gavage of the potato extract or other protein sources. The CCK-releasing activity of the potato extract was then examined in anesthetized rats with a portal cannula. Oral gavage of the potato extract reduced the food intake in the rats, the effect being greater than with casein and a soybean ß-conglycinin hydrolysate. The suppressive effect on appetite of the potato extract was attenuated by treating with a CCK-receptor antagonist (devazepide). The portal CCK concentration was increased after a duodenal administration of the potato extract to anesthetized rats. These results indicate that the potato extract suppressed the food intake in rats through CCK secretion.


Subject(s)
Appetite/drug effects , Cholecystokinin/metabolism , Eating/drug effects , Plant Extracts/administration & dosage , Solanum tuberosum/chemistry , Administration, Oral , Animals , Antigens, Plant/pharmacology , Appetite/physiology , Caseins/pharmacology , Cholecystokinin/biosynthesis , Devazepide/pharmacology , Duodenum/drug effects , Duodenum/physiology , Eating/physiology , Fasting , Globulins/pharmacology , Hormone Antagonists/pharmacology , Male , Rats , Rats, Sprague-Dawley , Receptors, Cholecystokinin/antagonists & inhibitors , Receptors, Cholecystokinin/metabolism , Satiation/drug effects , Satiation/physiology , Seed Storage Proteins/pharmacology , Soybean Proteins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL